Financial results

Takeda Pharmaceutical's IFRS net profit for fiscal 2019 was JPY 44.29 billion, down 3 times from JPY 135.08 billion the previous year. Revenue increased 56.9% to JPY 3.291 trillion compared to JPY 2.097 trillion a year earlier.